期刊文献+

Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis 被引量:6

原文传递
导出
摘要 Objective: MicroRNAs(miRNAs) may be viable targets for treating renal interstitial fibrosis(RIF). Fuzheng Huayu recipe(FZHY), a traditional Chinese compound herbal medicine, is often used in China to treat fibrosis. This study sought to assess the mechanisms through which FZHY influences miRNAs to treat RIF.Methods: RIF was induced in rats by mercury chloride and treated with FZHY. Hydroxyproline content,Masson’s staining and type I collagen expression were used to evaluate renal collagen deposition.Renal miRNA profiles were evaluated using a miRNA microarray. Those miRNAs that were differentially expressed following FZHY treatment were identified and subjected to bioinformatic analyses. The miR-21 target gene phosphatase and tensin homolog(PTEN) expression and AKT phosphorylation in kidney tissues were assessed via Western blotting. In addition, HK-2 human proximal tubule epithelial cells were treated using angiotensin II(Ang-II) to induce epithelial-to-mesenchymal transition(EMT), followed by FZHY exposure. miR-21 and PTEN expressions were evaluated via quantitative reverse transcriptionpolymerase chain reaction(qRT-PCR), while E-cadherin and a-smooth muscle actin(a-SMA) expressions were assessed by immunofluorescent staining and qRT-PCR. Western blotting was used to assess PTEN and AKT phosphorylation.Results: FZHY significantly decreased kidney collagen deposition, hydroxyproline content and type I collagen level. The miRNA microarray identified 20 miRNAs that were differentially expressed in response to FZHY treatment. Subsequent bioinformatic analyses found that miR-21 was the key fibrosis-related miRNA regulated by FZHY. FZHY also decreased PTEN expression and AKT phosphorylation in fibrotic kidneys. Results from in vitro tests also suggested that FZHY promoted E-cadherin upregulation and inhibited a-SMA expression in Ang-II-treated HK-2 cells, effectively reversing Ang-II-mediated EMT. We also determined that FZHY reduced miR-21 expression, increased PTEN expression and decreased AKT phosphorylation in these cells.Conclusion: miR-21 is the key fibrosis-related miRNA regulated by FZHY. The ability of FZHY to modulate miR-21/PTEN/AKT signaling may be a viable approach for treating RIF.
出处 《Journal of Integrative Medicine》 SCIE CAS CSCD 2020年第6期505-513,共9页 结合医学学报(英文版)
基金 supported by the National Natural Science Foundation of China (No. 81573810,81270053,81530101) China Postdoctoral Science Foundation (No. 2015T80445) National Science&Technology Major Project “Key New Drug Creation and Manufacturing Program” of China (No. 2019ZX09201001)。
  • 相关文献

参考文献4

二级参考文献57

  • 1Jun-Fang Zhao, Cheng-Hai Liu, Yi-Yang Hu, Lie-Ming Xu, Ping Liu and Cheng Liu Shanghai, China Institute of Liver Diseases, Shanghai University of Tra- ditional Chinese Medicine, Shanghai 200023 , China.Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):102-105. 被引量:17
  • 2袁继丽,刘成海,姜哲浩,张悦,刘成.口服氯化汞对大鼠肾间质纤维化的作用[J].中国实验动物学报,2006,14(2):93-95. 被引量:9
  • 3赵长青,吴艺青,徐列明.扶正化瘀胶囊抗肝纤维化的临床疗效和作用机制[J].中西医结合学报,2006,4(5):467-472. 被引量:63
  • 4陶艳艳,崔红燕,刘成海.大鼠肝纤维化病理过程中Smads锚着蛋白表达变化[J].中华肝脏病杂志,2006,14(12):909-913. 被引量:9
  • 5Ghosh A,Sil PC.A protein from Ca janus indicus Spreng protects liver and kidney against mercuric chlorideinduced oxidative stress.Biol Pharm Bull.2008; 31(9):1651-1658.
  • 6Vahter M,Akesson A,Lind B,Bj(o)rs U,Schütz A,Berglund M.Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women,as well as in umbilical cord blood.Environ Res.2000; 84(2):186-194.
  • 7Richer G,Ducrot H,Hamburger J,Legrain M,Maxwell M,Péquignot MH.May medical therapy of arterial hypertension by used in patients with renal failure?Presse Med.1968; 76(44):2103-2106.French.
  • 8Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecular mechanism,and therapeutic intervention.J Am Soc Nephrol.2004; 16(1):1-12.
  • 9Nielsen JB,Andersen O.Oral mercuric chloride exposure in mice:effects of dose on intestinal absorption and relative organ distribution.Toxicology.1989 ; 59(1):1-10.
  • 10Nielsen JB,Andersen O.Disposition and retention of mercuric chloride in mice after oral and parenteral administration.J Toxicol Environ Health.1990; 30(3):167-180.

共引文献72

同被引文献80

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部